CVE-2020-5625
4.3 Medium
CVSS2
Attack Vector
NETWORK
Attack Complexity
MEDIUM
Authentication
NONE
Confidentiality Impact
NONE
Integrity Impact
PARTIAL
Availability Impact
NONE
AV:N/AC:M/Au:N/C:N/I:P/A:N
6.1 Medium
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
REQUIRED
Scope
CHANGED
Confidentiality Impact
LOW
Integrity Impact
LOW
Availability Impact
NONE
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
6.5 Medium
AI Score
Confidence
High
0.002 Low
EPSS
Percentile
59.7%
Cross-site scripting vulnerability in XooNIps 3.48 and earlier allows remote attackers to inject an arbitrary script via unspecified vectors.
Affected configurations
| CPE | Name | Operator | Version |
|---|---|---|---|
| riken:xoonips | riken xoonips | le | 3.48 |
CNA Affected
[
{
"product": "XooNIps",
"vendor": "Neuroinformatics Unit, Integrative Computational Brain Science Collaboration Division, RIKEN Center for Brain Science",
"versions": [
{
"status": "affected",
"version": "3.48 and earlier"
}
]
}
]Related
4.3 Medium
CVSS2
Attack Vector
NETWORK
Attack Complexity
MEDIUM
Authentication
NONE
Confidentiality Impact
NONE
Integrity Impact
PARTIAL
Availability Impact
NONE
AV:N/AC:M/Au:N/C:N/I:P/A:N
6.1 Medium
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
REQUIRED
Scope
CHANGED
Confidentiality Impact
LOW
Integrity Impact
LOW
Availability Impact
NONE
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
6.5 Medium
AI Score
Confidence
High
0.002 Low
EPSS
Percentile
59.7%